We are live on ! Find out more
IMNN icon

Imunon
IMNN

21 hedge funds and large institutions have $818K invested in Imunon in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

6.07% less ownership

Funds ownership: 12.95% → 6.88% (-6.1%)

13% less funds holding

Funds holding: 24 → 21 (-3)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

86% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 7

90% less capital inflows, than outflows

Capital inflows: $95.1K | Capital outflows: $908K

Holders
21
Holders Change
-3
Holders Change %
-12.5%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
7
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$69K
2
Virtu Financial
Virtu Financial
New York
+$23.5K
3
Renaissance Technologies
Renaissance Technologies
New York
+$2.58K

Top Sellers

Rank Fund Capital Flow
1
Murchinson
Murchinson
Ontario, Canada
-$509K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$178K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$95K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$48K
5
Two Sigma Investments
Two Sigma Investments
New York
-$37K

IMNN Hedge Fund Activity: Q3 2022 in Review

21 of the 5,832 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q3 2022, worth a combined $818K — down 51% from $1.69M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of IMNN and 2 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 1 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $69K. The largest seller was Murchinson, exiting entirely with an estimated $509K sold.

  • 21 institutional investors held Imunon (IMNN) as of Q3 2022, down from 24 in Q2 2022.
  • Funds reported $818K of Imunon stock for Q3 2022, down 51% quarter-over-quarter.
  • 2 funds opened new Imunon positions in Q3 2022 and 5 closed out, a net change of -3 holders.
  • The largest Imunon buyer in Q3 2022 was Citadel Advisors, an estimated $69K added.
  • The largest Imunon seller in Q3 2022 was Murchinson, an estimated $509K sold.

Based on aggregated 13F filings for Q3 2022.